Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
JCO Precis Oncol
.
2020:4:736-742.
doi: 10.1200/PO.20.00063.
Epub 2020 Jun 24.
Authors
Elizabeth K Lee
1
,
Katharine M Esselen
2
,
David L Kolin
3
,
Larissa J Lee
4
,
Ursula A Matulonis
1
,
Panagiotis A Konstantinopoulos
1
Affiliations
1
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
2
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA.
3
Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA.
4
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Boston, MA.
PMID:
32704608
PMCID:
PMC7377332
DOI:
10.1200/PO.20.00063
No abstract available
Grants and funding
U10 CA180868/CA/NCI NIH HHS/United States
UM1 CA186709/CA/NCI NIH HHS/United States